Table 1

Patient characteristics
    CHARACTERISTIC
Age: Median (range) 61years (46–74 years)
Male 26 (58%)
Female 19 (42%)
Significant Bone disease1 23 (51%)
Time following completion of treatment 11months (median)
(range 3–149 months)
Previous ASCT2 42 (93%)
Previous orthopaedic surgery 6 (13%)
    Current therapies
Maintenance treatment 9 (20%)
• Lenalidomide 1
• Interferon 2
• Thalidomide 6
Regular analgesia 11 (24%)

Details are given of patient characteristics for the 45 patients who completed baseline screening.

1 with one or more of the following: bone pain, vertebral collapse, fractures.

2 autologous stem cell transplantation.

Groeneveldt et al.

Groeneveldt et al. BMC Cancer 2013 13:31   doi:10.1186/1471-2407-13-31

Open Data